|
METTL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.022600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.781870E-02 |
| Normal-vs-Stage2 |
1.738370E-01 |
| Normal-vs-Stage3 |
6.758300E-03 |
| Normal-vs-Stage4 |
2.941300E-03 |
| Stage1-vs-Stage2 |
7.757000E-01 |
| Stage1-vs-Stage3 |
5.638100E-02 |
| Stage1-vs-Stage4 |
7.9258000000082E-05 |
| Stage2-vs-Stage3 |
3.291200E-01 |
| Stage2-vs-Stage4 |
1.117740E-02 |
| Stage3-vs-Stage4 |
5.479600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.840100E-03 |
| Normal-vs-AfricanAmerican |
2.584100E-03 |
| Normal-vs-Asian |
1.826410E-01 |
| Caucasian-vs-AfricanAmerican |
1.797200E-01 |
| Caucasian-vs-Asian |
3.304800E-01 |
| AfricanAmerican-vs-Asian |
2.864600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.004400E-02 |
| Normal-vs-Female |
2.09449999999389E-05 |
| Male-vs-Female |
1.079500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.121500E-03 |
| Normal-vs-Extreme_Weight |
6.786400E-02 |
| Normal-vs-Obese |
3.489600E-02 |
| Normal-vs-Extreme_Obese |
3.866000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.736200E-02 |
| Normal_Weight-vs-Obese |
3.339800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.930600E-01 |
| Extreme_Weight-vs-Obese |
5.059800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.380400E-01 |
| Obese-vs-Extreme_Obese |
8.975400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.278900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.095000E-03 |
| Normal-vs-Age(61-80Yrs) |
5.273600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.836200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.036400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.040340E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.914000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.498800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.509400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.545600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.419900E-02 |
| Normal-VS-Type2 PRCC |
7.625000E-03 |
| Normal-VS-KIRP CIMP |
1.160000E-03 |
| Normal-VS-Unclassified PRCC |
4.443200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.980840E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.519400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.359800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.196020E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.828770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.56840999999686E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.077400E-01 |
| Normal-vs-N1 |
1.007730E-04 |
| Normal-vs-N2 |
5.200800E-01 |
| N0-vs-N1 |
7.172900E-04 |
| N0-vs-N2 |
5.894400E-01 |
| N1-vs-N2 |
3.290800E-01 |
|
|
